Significant low expression was also found in TN (ER−/PR−/HER2−) compared with ER+ tumours (ER+/PR+/HER2+ or ER+/PR+/HER2−), which is consistent with our findings in CSC (Fig. 3d). Here, ERBB2 is linked to neoplasm.